Jordi Serrats - Publications

Affiliations: 
Takeda California 
Area:
Drug Discovery

21/27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Serrats J, Grigoleit JS, Alvarez-Salas E, Sawchenko PE. Pro-Inflammatory Immune-to-Brain Signaling is Involved in Neuroendocrine Responses to Acute Emotional Stress. Brain, Behavior, and Immunity. PMID 28179107 DOI: 10.1016/J.Bbi.2017.02.003  0.632
2012 Mohammad MG, Hassanpour M, Tsai VW, Li H, Ruitenberg MJ, Booth DW, Serrats J, Hart PH, Symonds GP, Sawchenko PE, Breit SN, Brown DA. Dendritic cells and multiple sclerosis: disease, tolerance and therapy. International Journal of Molecular Sciences. 14: 547-62. PMID 23271370 DOI: 10.3390/Ijms14010547  0.501
2011 Roe AD, Staup MA, Serrats J, Sawchenko PE, Rissman RA. Lipopolysaccharide-induced tau phosphorylation and kinase activity--modulation, but not mediation, by corticotropin-releasing factor receptors. The European Journal of Neuroscience. 34: 448-56. PMID 21722209 DOI: 10.1111/J.1460-9568.2011.07764.X  0.551
2010 Serrats J, Schiltz JC, García-Bueno B, van Rooijen N, Reyes TM, Sawchenko PE. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron. 65: 94-106. PMID 20152116 DOI: 10.1016/J.Neuron.2009.11.032  0.65
2010 Yu Y, Zhang ZH, Wei SG, Serrats J, Weiss RM, Felder RB. Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension. 55: 652-9. PMID 20142564 DOI: 10.1161/Hypertensionaha.109.142836  0.42
2009 García-Bueno B, Serrats J, Sawchenko PE. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 12970-81. PMID 19828811 DOI: 10.1523/Jneurosci.2373-09.2009  0.648
2009 Serrats J, Sawchenko PE. How T-cell-dependent and -independent challenges access the brain: vascular and neural responses to bacterial lipopolysaccharide and staphylococcal enterotoxin B. Brain, Behavior, and Immunity. 23: 1038-52. PMID 19524662 DOI: 10.1016/J.Bbi.2009.06.004  0.634
2006 Steiner AA, Ivanov AI, Serrats J, Hosokawa H, Phayre AN, Robbins JR, Roberts JL, Kobayashi S, Matsumura K, Sawchenko PE, Romanovsky AA. Cellular and molecular bases of the initiation of fever. Plos Biology. 4: e284. PMID 16933973 DOI: 10.1371/Journal.Pbio.0040284  0.576
2006 Bové J, Serrats J, Mengod G, Cortés R, Aguilar E, Marin C. Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. Synapse (New York, N.Y.). 59: 435-44. PMID 16498608 DOI: 10.1002/Syn.20259  0.319
2006 Serrats J, Sawchenko PE. CNS activational responses to staphylococcal enterotoxin B: T-lymphocyte-dependent immune challenge effects on stress-related circuitry. The Journal of Comparative Neurology. 495: 236-54. PMID 16435288 DOI: 10.1002/Cne.20872  0.624
2005 Bové J, Serrats J, Mengod G, Cortés R, Tolosa E, Marin C. Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. Experimental Brain Research. 165: 362-74. PMID 15968457 DOI: 10.1007/S00221-005-2302-1  0.358
2005 Serrats J, Mengod G, Cortés R. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. Journal of Chemical Neuroanatomy. 29: 83-91. PMID 15652696 DOI: 10.1016/J.Jchemneu.2004.03.010  0.353
2005 Marin C, Bové J, Serrats J, Cortés R, Mengod G, Tolosa E. The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons. Experimental Neurology. 191: 41-52. PMID 15589511 DOI: 10.1016/J.Expneurol.2004.08.033  0.35
2004 Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 1100-9. PMID 15115744 DOI: 10.1093/Cercor/Bhh070  0.346
2004 Amargós-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 281-99. PMID 14754868 DOI: 10.1093/Cercor/Bhg128  0.357
2004 Serrats J, Artigas F, Mengod G, Cortés R. An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 27-34. PMID 14720318 DOI: 10.1017/S1461145703003924  0.345
2004 Serrats J, Raurich A, Vilaró MT, Mengod G, Cortés R. 5-ht5B receptor mRNA in the raphe nuclei: coexpression with serotonin transporter. Synapse (New York, N.Y.). 51: 102-11. PMID 14618677 DOI: 10.1002/Syn.10287  0.33
2003 Bortolozzi A, Amargós-Bosch M, Adell A, Díaz-Mataix L, Serrats J, Pons S, Artigas F. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. The European Journal of Neuroscience. 18: 1235-46. PMID 12956722 DOI: 10.1046/J.1460-9568.2003.02829.X  0.325
2003 Serrats J, Artigas F, Mengod G, Cortés R. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. Journal of Neurochemistry. 84: 743-52. PMID 12562519 DOI: 10.1046/J.1471-4159.2003.01557.X  0.342
2003 Serrats J, Mengod G, Cortés R. S.04.06 Cellular localization of 5-HT1A, 5-HT1B and α1B receptor mRNAs in the raphe nuclei. A double in situ hybridization study throughout the raphe nuclei European Neuropsychopharmacology. 13: S104. DOI: 10.1016/S0924-977X(03)91614-2  0.316
2002 Serrats J, Mengod G, Cortés R. Cellular localization of neurotransmitter receptors involved in the local control of serotonergic neurons: A double in situ hybridization study throughout the midbrain raphé nuclei European Neuropsychopharmacology. 12: 253-254. DOI: 10.1016/S0924-977X(02)80327-3  0.306
Low-probability matches (unlikely to be authored by this person)
2017 Serrats J, Cunningham MO, Davies CH. GABAB receptor modulation-to B or not to be B a pro-cognitive medicine? Current Opinion in Pharmacology. PMID 29050820 DOI: 10.1016/J.Coph.2017.09.012  0.281
2019 Fradley R, Goetghebeur P, Miller D, Burley R, Serrats J. S22. PRE-CLINICAL ASSESSMENT OF TAK-831, A SELECTIVE D-AMINO ACID OXIDASE INHIBITOR, IN ANIMAL MODELS OF SCHIZOPHRENIA Schizophrenia Bulletin. 45: S313-S314. DOI: 10.1093/Schbul/Sbz020.567  0.205
2021 Reichard HA, Schiffer HH, Monenschein H, Atienza JM, Corbett G, Skaggs AW, Collia DR, Ray WJ, Serrats J, Bliesath J, Kaushal N, Lam BP, Amador-Arjona A, Rahbaek L, McConn DJ, et al. Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia. Journal of Medicinal Chemistry. PMID 34260228 DOI: 10.1021/acs.jmedchem.1c00820  0.17
2022 Maus KD, Stephenson DJ, Ali AN, MacKnight HP, Huang HJ, Serrats J, Kim M, Diegelmann RF, Chalfant CE. Ceramide kinase regulates acute wound healing by suppressing 5-oxo-ETE biosynthesis and signaling via its receptor OXER1. Journal of Lipid Research. 100187. PMID 35219746 DOI: 10.1016/j.jlr.2022.100187  0.168
2023 Fradley R, Goetghebeur P, Miller D, Burley R, Almond S, Gruart I Massó A, Delgado García JM, Zhu B, Howley E, Neill JC, Grayson B, Gaskin P, Carlton M, Gray I, Serrats J, et al. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia. Neurochemical Research. PMID 37289348 DOI: 10.1007/s11064-023-03956-2  0.128
2023 Fradley R, Goetghebeur P, Miller D, Burley R, Almond S, Gruart I Massó A, Delgado García JM, Zhu B, Howley E, Neill JC, Grayson B, Gaskin P, Carlton M, Gray I, Serrats J, et al. Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia. Neurochemical Research. PMID 37440119 DOI: 10.1007/s11064-023-03987-9  0.045
Hide low-probability matches.